Moreover, Muakkassa et al. approached this characterization of treatment-naïve CNV after anti-VEGF treatment on a larger spectrum of retinal pathology (from naMD to neovascularized idiopathic macular telangiectasia or multifocal choroiditis), also measuring the greatest linear dimension and area of these CNV. The gene discussed is VEGFA; the disease is multifocal choroiditis.